Sunday, March 03, 2019 1:59:10 AM
The 4 analysts offering 12-month price forecasts for Achillion Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 5.00. The median estimate represents a +105.99% increase from the last price of 2.67.
The current consensus among 4 polled investment analysts is to buy stock in Achillion Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a buy rating.
Origin
https://money.cnn.com/quote/quote.html?symb=ACHN
Stock Invest says
Today ACHN ranks #1287 as BUY CANDIDATE
StockCharts.com
https://stockcharts.com/h-sc/ui?s=ACHN
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM